Tuesday, 27 October 2015 - Pre-conference courses Wednesday, 28 October 2015 Thursday, 29 October 2015
Friday, 30 October 2015 Detailed List of Posters

Conference day 1 - Wednesday, 28 October 2015

Zenit Nadir
08:00 - 09:00 Registration
09:00 - 09:30 Opening Ceremony
09:30 - 10:30 Opening Lecture / CIOMS Keynote Lecture                
Chair: Gunilla Sjölin-Forsberg (Switzerland)                
O 33: Beyond Protection: The Integrity of Science as a Fundamental Ethical Concern                
Speaker: Alex John London (USA)  
             
10:30 - 11:00 Coffee Break and Poster viewing
11:00 - 11:45 Keynote Lecture 1
Chair: Jan Petráček (Czech Republic)                
O 02: The Future of pharmacovigilance                 
Speaker: Peter Arlett (UK)                
11:45 - 12:30 Keynote Lecture 2                
Chair: Gunilla Sjölin-Forsberg (Switzerland)                
O 03: Big data including social media. Global perspectives                
Speaker: Marie Lindquist (Sweden)                
12:30 - 14:00 Lunch
14:00 - 15:30 Parallel session A 
Risk Management in Pharmacotherapy     
Chairs: Jan Petráček (Czech Republic), 
Ghita Benabdallah (Morocco)    
14:00 - 15:30 Parallel session B    
Vaccines     
Chairs: Gunilla Sjölin-Forsberg (Switzerland), Tatiana Belkina (Czech Republic)    
14:00 - 14:20 O 04: Medication errors – EU regulatory initiatives on risk minimisation and error prevention
Speaker: Thomas Goedecke (UK)
14:00 - 14:30 O 09: Methodologies for vaccine safety surveillance 
Speaker: Nick Andrews (UK)
14:20 - 14:40 O 05: WHO guideline: Reporting and learning systems for medication errors: the role of pharmacovigilance centres
Speaker: Ghita Benabdallah (Morocco)
14:30 - 14:45 O 10: Signal detection methods for vaccine spontaneous report data
Speaker: Lionel Van Holle (Belgium)
14:40 - 15:00 O 06: Patient adherence and patient safety
Speaker: Bernard Vrijens (Belgium)
14:45 - 15:00 O 11: Monitoring adverse events following influenza vaccination in general practice: Evaluation of different methods to increase the inclusion rate of patients
Speaker: Leontine van Balveren (The Netherlands)
15:00 - 15:15 O 07: Evaluating prescriber concordance with prescribing: results from a post-marketing study in primary care setting
Speaker: Saad Shakir (UK)
15:00 - 15:15 O 12: Identification of vaccine safety signals in VigiBase
Speaker: Rebecca Chandler (Sweden)
15:15 - 15:30 O 08: Medication errors detected among the spontaneously reported adverse drug reactions to the Croatian Agency for Medicinal Products and Medical Devices
Speaker: Viola Macolić Šarinić (Croatia)
15:15 - 15:30 O 13: Asymptomatic Immunization errors  reporting in Morocco
Speaker: Amina Tebaa (Morocco)
15:30 - 16:00 Coffee Break and Poster viewing                
16:00 - 17:30 Parallel session C    
Risks and benefits of medicines for women     
Chairs: 
Mira Harrison-Woolrych (UK), Jiří Vlček (Czech Republic)    
16:00 - 17:30 Parallel session D    
Benefit/Burden of pharmacovigilance     
Chairs: Marco Tuccori (Italy), Veronique Kugener (USA)    
16:00 - 16:30 O 14: Medicines for Women: Medicines for Half the World
Speaker: Mira Harrison-Woolrych (UK)
16:00 - 16:30 O 19: Another perspective in pharmacovigilance
Speaker: Eugene van Puijenbroek (The Netherlands)
16:30 - 16:45 O 15: Evidence-based use of menopausal hormone therapy
Speaker: Emily Banks (Australia)
16:30 - 16:45 Panel discussion
16:45 - 17:00 O 16: Safety of medicines during breastfeeding
Speaker: Eva Jirsová (Czech Republic)
16:45 - 17:00 O 20: An Assessment of Utility and Burden Associated with the Vandetanib (CAPRELSA®) Restricted Distribution Program in Canada
Speaker: Yola Moride (Canada)
17:00 - 17:15 O 17: A woman is not like a man: why risk communication for women is a whole new game
Speaker: Bruce Hugman (Sweden)
17:00 - 17:15
O 21: Building Up a Signal Management Framework For a Resource-limited Health Authority
Speaker: Wen-Wen Chen (Taiwan Republic of China)

17:15 - 17:30
Discussion
17:15 - 17:30 O 59: Estimation of theoretical cost preventability achievable with an effective pharmacovigilance activity in a Pharmacovigilance Regional Centre in Italy
Speaker: Alice Capogrosso Sansone (Italy)

17:30 - 19:00 Chapters meeting 17:30 - 19:00 CommSIG meeting

Conference day 2 - Thursday, 29 October 2015

Zenit Nadir
08:30 - 10:15 Parallel session E    
The roles of PV centers and community involvement     
Chairs: Everardo Vazquez (Mexico), Veronika Deščíková (Czech Republic) 
08:30 - 10:15 Parallel session F    
Emerging sources of PV data    
Chairs: Yola Moride (Canada), Martin Votava (Czech Republic) 
08:30 - 09:00 O 22: Patients involvement for a better PV knowledge
Speaker: Linda Härmark (The Netherlands)
08:30 - 09:00 O 27: Use of social media for data mining in pharmacovigilance
Speaker: Nabarun Dasgupta (USA)
09:00 - 09:30 O 23: Coordinating the WHO Drug Monitoring Programme: the role of WHO Collaborating Centres
Speaker: Clive Ondari (Switzerland)
09:00 - 09:15 O 28: Integrating Pharmacogenomics with Pharmacovigilance - Croatian Experience
Speaker: Viola Macolić Šarinić (Croatia)
09:30 - 09:45 O 24: Knowledge about adverse drug reaction and reporting among the healthcare professionals in Bhutan
Speaker: Choki Dorji (Bhutan)
09:15 - 09:30 O 29: Factors influencing adverse drug reactions reporting by patients – a cross-sectional study from Bulgaria
Speaker: Hristina Lebanova (Bulgaria)
09:45 - 10:00 O 25: The impact of ADRs on patient’s quality of life after packaging changes of the drug Thyrax®
Speaker: Leàn Rolfes (The Netherlands)
09:30 - 09:45 O 30: Adverse Drugs Reactions (ADR) collected by Medical Staffed Ambulances:  pilot study
Speaker: Agnès Lillo-Le Louët (France)
09:45 - 10:00 O 31: The effect of regulatory definitions on mining social media for adverse events: A real-world examination
Speaker: Michael Ibara (USA)
10:00 - 10:15 O 26: Enforcing the habit – the role of champions in pharmacovigilance education
Speaker: Karamjit Khangura (UK)
10:00 - 10:15 O 32: Exploiting Heterogeneous Open Data for Pharmacovigilance
Speaker: Vassilis Koutkias (France)
10:15 - 10:45 Coffee Break and Poster viewing                
10:45 - 11:45 Keynote Lecture 3
Chair: Jan Petráček (Czech Republic)               
O 01: Patient Safety Today – From Identifying Problems to Implementing Solutions               
Speaker: Nick Sevdalis (UK) 
               
11:45 - 12:45 Lunch                
12:45 - 14:45 ISoP General Assembly and Presentation ISoP Annual Meeting 2016             
14:45 - 16:15 O 34: PRAC session and Round-table discussion                 
Chairs: Hervé Le Louët (France), June Raine (UK)                            
14:45 - 15:00 Progress in 3 years of pharmacovigilance in EU – key success factors and ongoing challenges           
Speaker: Peter Arlett (UK)
 
15:00 - 15:15 Perspective from a member state on PRAC delivering strengthened public health protection              
Speaker: Jana Mladá (Czech Republic) 
 
15:15 - 15:30 PRAC’s best evidence in pharmacovigilance strategy           
Speaker: Dolores Montero (Spain)
15:30 - 15:45 Key improvements for PRAC moving forward           
Speaker: June Raine (UK)
 
15:45 - 16:15 Round-table / Panel discussion   
16:15 - 16:45 Coffee Break and Poster viewing                
16:45 - 18:00 Parallel session G    
Hospital Pharmacovigilance, ADR reporting in patients and Clinical Epidemiology     
Chairs: Victoria Rollason (Switzerland), Ulrich Hagemann (Germany)    
16:45 - 18:00 Parallel session H    
Herbals     
Chairs: Souad Skalli (Morocco), Marie Heroutová (Czech Republic)
16:45 - 17:00 O 35: US health care professional perspectives on adverse drug event reporting in the hospital setting and the opportunity for information technology
Speaker: Gustavo Grampp (USA)
16:45 - 17:15 O 39: Do we need new and specific methods for PV of herbal medicines?
Speaker: Souad Skalli (Morocco)
17:00 - 17:15 O 36: Triggers of Active Surveillance of Adverse Drug Events in Hospitalized Newborns: A Pilot Study
Speaker: Sandra Carvalho Fabretti (Brazil)
17:15 - 17:30 O 40: Impediments in the monitoring of drugs of Traditional system of Medicine
Speaker: K. C. Singhal (India)
17:15 - 17:30 O 37: Strategies for detection adverse drug reactions – comparison of hospital database and spontaneous reporting
Speaker: Joana Marques (Portugal)
17:30 - 17:45 O 58: Dietary Supplements Used In Bodybuilding: Possible Serious Adverse Effects
Speaker: Louise Gaboriau (France)
17:30 - 17:45 O 38: Implementation of pharmacovigilance in clinical sitting: national oncology institute experience
Speaker: Houda Sefiani (Morocco)
17:45 - 18:00 O 42: Safety of red rice yeast food supplements
Speaker: Francesca Menniti Ippolito (Italy)
17:45 - 18:00 Discussion
19:30 Meeting Dinner

Conference day 3 - Friday, 30 October 2015

Zenit Nadir
09:00 - 10:30 Parallel session I    
Hot topics around the cube (selection of the best abstracts)    
Chairs: Gaby Danan (France), Petra Matoulková (Czech Republic)    
09:00 - 10:30 Parallel session J    
New methodologies in Signal detection and Safety surveillance     
Chairs: Andrew Bate (UK), Radek Běla (Czech Republic)    
09:00 - 09:30 O 43: Drug-Induced Liver Injury: Where Are We in 2015?
Speaker: Gaby Danan (France)   
09:00 - 09:30 O 47: Multivariate Analysis for Visualizing Pharmacovigilance Data
Speaker: Manfred Hauben (USA)
09:30 - 09:45 O 44: Cohort study of blood dyscrasias associated with the use of proton pump inhibitors (PPIs)
Speaker: Carmen D'Amore (Italy)
09:30 - 09:50 O 48: WEB-RADR: Use of mobile technologies and social media in pharmacovigilance
Speaker: Phil Tregunno (UK)
09:45 - 10:00 O 45: Effect of glyburide compared with other second-generation sulfonylureas on the risk of cancer in patients with type 2 diabetes mellitus
Speaker: Marco Tuccori (Italy)
09:50 - 10:10 O 49: Tuning epidemiological study design methods for exploratory data analysis in real world data
Speaker: Andrew Bate (UK)
10:00 - 10:15 O 46: Challenges of evaluating the safety profile of non-active implantable medical devices compared to medicinal products
Speaker: Josep Pané (Spain)
10:10 - 10:20 O 50: Spontaneous reports and electronic health records for safety signal detection – yin and yang
Speaker: Alexandra Pacurariu (The Netherlands)
10:15 - 10:30 Discussion 10:20 - 10:30 O 51: Adverse event cluster analysis for syndromic surveillance
Speaker: Rebecca Chandler (Sweden)
10:30 - 11:00 Coffee Break              
11:00 - 11:30 Keynote Lecture 4            
Chair: Jiří Vlček (Czech Republic)               
O 52: Role of Genomics in Pharmacovigilance                
Speaker: Ondřej Slanař (Czech Republic)                     
11:30 - 13:00 Bengt Erik Wiholm Lecture                 
O 53: Patient safety through dialogue – how to better connect pharmacovigilance and healthcare?                 
Chairs: Priya Bahri (UK), Brian Edwards                
11:30 - 11:40 O 54: Healthcare professionals’ perspectives on regulatory safety communication about medicines: The Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action            
Speaker: Peter Mol (The Netherlands)            
11:40 - 11:50 O 55: Overview on risk communication in EU - Highlights from Croatia as regional example            
Speaker: Viola Macolić Sarinić (Croatia)            
11:50 - 12:00 O 56: Talking about harm and benefit information – the challenges in healthcare practice            
Speaker: DK Theo Raynor (UK)            
12:00 - 12:10 O 57: Risk factors, psychology and communication             
Speaker: Hansjörg Neth (Germany)            
12:10 - 13:00 Round-table / Panel discussion             
13:00 - 13:15 Poster Prize Ceremony                
Closing Ceremony of ISoP 2015                
13:15 - 14:15 Light lunch                

   
 
Meeting Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | info@isop2015prague.org
Copyright © 2014 isop2015prague.org | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2